Tipsheet
What matters at India’s listed companies
Earnings · Electric Equipment · Mid cap

Saatvik pushes Odisha cell plant to H2 FY27, plans ₹1,700 cr capex

Management blamed Q4 margin compression on commodity prices and a weak rupee. The ₹1,700 cr spending plan for FY27 is a mix of debt and accruals.

6 earlier stories on Saatvik Green Energy Ltd.
Mkt cap₹6,092 cr
P/E17.05×
ROE63.41%
Debt / eq.1.36
₹1,700 cr Estimated capex for FY27, funded by debt and accruals.

What's new

  • Odisha cell production now targeted for H2 FY27, a delay from prior guidance.
  • Q4 margins squeezed by commodity price spikes and rupee depreciation.
  • Encapsulant capacity to expand from 2 GW to 5 GW.

Why this matters

The Odisha delay pushes Saatvik's revenue from high-value cell production further out, just as domestic cell capacity is expected to come online. The ₹1,700 cr capex plan, funded by a 1x-1.5x debt-equity ratio, is large for a company whose margins are already under pressure from input costs.

What we're watching

  • Execution of the Odisha plant ramp in H2 FY27.
  • Whether the 1x-1.5x debt-equity ratio holds as capex progresses.
  • Margin recovery as commodity prices and FX stabilize.

The full read

Saatvik Green Energy's Q4 call confirms a ₹1,700 crore capex plan for FY27. That spending, aimed at building out cells and encapsulant capacity, is a large commitment for a firm whose margins just got squeezed by commodity prices and a weak rupee. The company says it will keep debt-equity between 1x and 1.5x, but the funding mix leans on both accruals and new borrowings. The most consequential detail is the delay: Odisha cell production is now slated for H2 FY27, pushing revenue from that facility further into the future. Encapsulant capacity is scaling from 2 GW to 5 GW, and the 6 GW cell target for mid-2027 is still on schedule. The margin pressure from this quarter won't disappear just because a new plant opens.

Questions answered

Why was Q4 margin performance weak?
Management cited two factors: a sharp rise in commodity prices and a depreciation of the rupee linked to the ongoing war. Both increased input costs during the quarter.
What is the new timeline for Odisha cell production?
Saatvik now plans to start production at its 2.4 GW Odisha facility in the second half of FY27. This is later than earlier guidance suggested.
How will the ₹1,700 crore capex be funded?
The capex will be funded through a mix of internal accruals and debt. Management stated the debt-equity ratio is expected to stay within a range of 1x to 1.5x.
What other capacity expansions are planned?
Encapsulant capacity is set to expand from 2 GW to 5 GW. The target of 6 GW for solar cell production by mid-2027 remains on track, separate from the Odisha timeline.
Mentioned: Odisha facility · ₹1,700 cr capex · 2 GW to 5 GW encapsulant
Primary source BSE · NSE · Tijori

An independent reading of the company's own disclosure — the primary filing above is the final word.

Company snapshot

Saatvik Green Energy Ltd.

Engineering & Capital Goods
₹5,481 cr
P/E 15.34×

Latest quarter · Mar 2026

Sales₹1,608 cr
Net profit₹60 cr
Op. margin+6.7%
EPS₹4.77

Strength & growth

Debt / equity1.36×
Current ratio1.14×
  1. 25 May 2026 · 5:38 PM IST Saatvik pushes Odisha cell plant to H2 FY27, plans ₹1,700 cr capex
  2. 41d ago Saatvik locks in ₹171 cr solar order, but the counterparty stays in the dark
  3. 46d ago Saatvik Green delays 4 GW plant, production pushed past Q1 FY27
  4. 47d ago Saatvik Green Energy revenue jumps 111%, PAT rises 64% in FY26
  5. 47d ago Saatvik Green's standalone profit plunged 60% as subsidiary drove group growth